These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 4490310

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB, Fernandes LA, Fernandes CJ.
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [Abstract] [Full Text] [Related]

  • 43. Joint action of beta-lactam antibiotics.
    Cheung KS, Maniar AC.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):309-15. PubMed ID: 4996194
    [No Abstract] [Full Text] [Related]

  • 44. Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.
    Waitz JA, Drube CG, Moss EL, Weinstein MJ.
    J Antibiot (Tokyo); 1972 Nov; 25(11):647-52. PubMed ID: 4486485
    [No Abstract] [Full Text] [Related]

  • 45. In vitro susceptibility of Streptococcus bovis to six antibiotics.
    Klein RS, Milazzo JJ, Edberg SC.
    Clin Ther; 1984 Nov; 6(4):518-23. PubMed ID: 6467280
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.
    Karchmer AW, Moellering RC, Watson BK.
    Antimicrob Agents Chemother; 1975 Feb; 7(2):164-7. PubMed ID: 1137367
    [Abstract] [Full Text] [Related]

  • 48. Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin.
    Watanakunakorn C.
    J Antimicrob Chemother; 1990 Oct; 26(4):602-4. PubMed ID: 2254232
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Microbiological assay for cytosine arabinoside (NSC-63878) in biologic materials containing other antitumor or antibacterial drugs.
    Hanka LJ.
    Cancer Chemother Rep; 1971 Dec; 55(5):557-60. PubMed ID: 5003620
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.
    Krogstad DJ, Pargwette AR.
    Antimicrob Agents Chemother; 1980 Jun; 17(6):965-8. PubMed ID: 6902640
    [Abstract] [Full Text] [Related]

  • 54. Resistance of Streptococcus agalactiae to erythromycin.
    Von Recklinghausen G, Fischer W, Schmidt K, Ansorg R.
    J Antimicrob Chemother; 1989 Jul; 24(1):93. PubMed ID: 2674106
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Clostridial myonecrosis ('gas gangrene') during cephalosporin prophylaxis.
    Mohr JA, Griffiths W, Holm R, Garcia-Moral C, Flournoy DJ.
    JAMA; 1978 Feb 27; 239(9):847-9. PubMed ID: 245409
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Evaluation of a new differential test for enterococci in the clinical laboratory.
    von Graevenitz A, Redys JJ, Cassidy E.
    J Med Microbiol; 1970 May 27; 3(2):227-31. PubMed ID: 5201539
    [No Abstract] [Full Text] [Related]

  • 60. Penicillin tolerance in beta-streptococci.
    Woolfrey BJ.
    Scand J Infect Dis; 1988 May 27; 20(2):235-7. PubMed ID: 3399839
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.